143 related articles for article (PubMed ID: 9918404)
1. Immunization with the N-terminal region of the nonstructural protein NS1 promotes survival after challenge with lethal influenza A virus dose.
Tamura M; Saikh KU; Kurane I; Ennis FA
Viral Immunol; 1998; 11(3):131-5. PubMed ID: 9918404
[TBL] [Abstract][Full Text] [Related]
2. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
Lawson CM; Bennink JR; Restifo NP; Yewdell JW; Murphy BR
J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
[TBL] [Abstract][Full Text] [Related]
3. Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
Mbawuike IN; Dillion SB; Demuth SG; Jones CS; Cate TR; Couch RB
Vaccine; 1994 Nov; 12(14):1340-8. PubMed ID: 7856302
[TBL] [Abstract][Full Text] [Related]
4. Protective cross-reactive epitope on the nonstructural protein NS1 of influenza A virus.
Saikh KU; Tamura M; Kuwano K; Dai LC; West K; Ennis FA
Viral Immunol; 1993; 6(4):229-36. PubMed ID: 7513168
[TBL] [Abstract][Full Text] [Related]
5. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response.
Kuwano K; Scott M; Young JF; Ennis FA
J Immunol; 1988 Feb; 140(4):1264-8. PubMed ID: 2449498
[TBL] [Abstract][Full Text] [Related]
6. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
[TBL] [Abstract][Full Text] [Related]
7. Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes.
Kuwano K; Scott M; Young JF; Ennis FA
J Exp Med; 1989 Apr; 169(4):1361-71. PubMed ID: 2466942
[TBL] [Abstract][Full Text] [Related]
8. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
9. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
10. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
[TBL] [Abstract][Full Text] [Related]
11. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
[TBL] [Abstract][Full Text] [Related]
12. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
[TBL] [Abstract][Full Text] [Related]
13. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
[TBL] [Abstract][Full Text] [Related]
14. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
15. CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR
Marín-López A; Calvo-Pinilla E; Barriales D; Lorenzo G; Brun A; Anguita J; Ortego J
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875250
[TBL] [Abstract][Full Text] [Related]
16. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines.
Ikonomidis G; Portnoy DA; Gerhard W; Paterson Y
Vaccine; 1997 Mar; 15(4):433-40. PubMed ID: 9141215
[TBL] [Abstract][Full Text] [Related]
17. Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papilloma virus 16 in H-2d mice.
Zhu X; Tommasino M; Vousden K; Sadovnikava E; Rappuoli R; Crawford L; Kast M; Melief CJ; Beverley PC; Stauss HJ
Scand J Immunol; 1995 Nov; 42(5):557-63. PubMed ID: 7481562
[TBL] [Abstract][Full Text] [Related]
18. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin.
Staneková Z; Adkins I; Kosová M; Janulíková J; Sebo P; Varečková E
Antiviral Res; 2013 Jan; 97(1):24-35. PubMed ID: 23036818
[TBL] [Abstract][Full Text] [Related]
19. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
20. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
